Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

236 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[A case of pancreatic acinar cell carcinoma with a giant liver metastasis successfully treated with combination of gemcitabine and peroral S-1].
Nishimizu T, Minemura M, Kajiura S, Tokimitsu Y, Itaya Y, Yamawaki H, Kawai K, Tajiri K, Nakayama Y, Hosokawa A, Takahara T, Yasumura S, Shimizu S, Fukuoka J, Ishizawa S, Sawasaki T, Yanagisawa A, Sugiyama T. Nishimizu T, et al. Among authors: hosokawa a. Gan To Kagaku Ryoho. 2011 Feb;38(2):309-12. Gan To Kagaku Ryoho. 2011. PMID: 21368502 Japanese.
Randomised phase II study comparing dose-escalated weekly paclitaxel vs standard-dose weekly paclitaxel for patients with previously treated advanced gastric cancer.
Shitara K, Yuki S, Tahahari D, Nakamura M, Kondo C, Tsuda T, Kii T, Tsuji Y, Utsunomiya S, Ichikawa D, Hosokawa A, Ishiguro A, Sakai D, Hironaka S, Oze I, Matsuo K, Muro K. Shitara K, et al. Among authors: hosokawa a. Br J Cancer. 2014 Jan 21;110(2):271-7. doi: 10.1038/bjc.2013.726. Epub 2013 Nov 26. Br J Cancer. 2014. PMID: 24281004 Free PMC article. Clinical Trial.
Pertuzumab plus trastuzumab and chemotherapy for Japanese patients with HER2-positive metastatic gastric or gastroesophageal junction cancer: a subgroup analysis of the JACOB trial.
Shitara K, Hara H, Yoshikawa T, Fujitani K, Nishina T, Hosokawa A, Asakawa T, Kawakami S, Muro K. Shitara K, et al. Among authors: hosokawa a. Int J Clin Oncol. 2020 Feb;25(2):301-311. doi: 10.1007/s10147-019-01558-z. Epub 2019 Oct 16. Int J Clin Oncol. 2020. PMID: 31620931 Free PMC article. Clinical Trial.
Randomized, Phase II Study of Trastuzumab Beyond Progression in Patients With HER2-Positive Advanced Gastric or Gastroesophageal Junction Cancer: WJOG7112G (T-ACT Study).
Makiyama A, Sukawa Y, Kashiwada T, Kawada J, Hosokawa A, Horie Y, Tsuji A, Moriwaki T, Tanioka H, Shinozaki K, Uchino K, Yasui H, Tsukuda H, Nishikawa K, Ishida H, Yamanaka T, Yamazaki K, Hironaka S, Esaki T, Boku N, Hyodo I, Muro K. Makiyama A, et al. Among authors: hosokawa a. J Clin Oncol. 2020 Jun 10;38(17):1919-1927. doi: 10.1200/JCO.19.03077. Epub 2020 Mar 24. J Clin Oncol. 2020. PMID: 32208960 Clinical Trial.
Long-term survivor of gastric small cell carcinoma.
Hosokawa A, Shimada Y, Shirao K, Matsumura Y, Yamada Y, Muro K, Hamaguchi T, Gotoh M, Shimoda T. Hosokawa A, et al. Hepatogastroenterology. 2004 Sep-Oct;51(59):1567-70. Hepatogastroenterology. 2004. PMID: 15362803
236 results